Nanoscale Horiz., 2021, Advance Article
DOI: 10.1039/D0NH00624F, Communication
DOI: 10.1039/D0NH00624F, Communication
Byungji Kim, Qinglin Yang, Leslie W. Chan, Sangeeta N. Bhatia, Erkki Ruoslahti, Michael J. Sailor
RNAi-mediated immunotherapy provided by fusogenic porous silicon nanoparticles demonstrates superior therapeutic efficacy against both Gram-positive and Gram-negative bacterial infections compared with first-line antibiotics.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry
RNAi-mediated immunotherapy provided by fusogenic porous silicon nanoparticles demonstrates superior therapeutic efficacy against both Gram-positive and Gram-negative bacterial infections compared with first-line antibiotics.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry